1. All Products
  2. RIFAPENTINE, 150mg, disp. tab., blister
Public Pricelist

RIFAPENTINE, 150mg, disp. tab., blister

https://medicalguidelines.msf.org/en/node/575
https://unicat.msf.org/cat/product/93882
NST DORARIFP1TD1

Valid Article

Article is intended to be used with children (<12 years) ONLY.
6.2.5 - Antituberculosis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J04AB05
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

RIFAPENTINE

Therapeutic Action

Rifamycin, bactericidal

Indications

Latent Tuberculosis Infection (LTI-TB)

Instructions for use

Tablets can be crushed and mixed into a spoon with a small amount of food.

The 150 mg tablet is intended for children below 14 years.

Must be taken with food.

For children over 14 years of age and adults, when rifapentine is used in combination with isoniazid, a fixed-dose combination (FDC) is available: ISONIAZID 300mg / RIFAPENTINE, 300mg, tab., blister.

Blister packaging is the packaging of choice for antituberculosis medicines due to the unstable nature of some of them when exposed to higher temperatures and humidity.

The quantity to be ordered is calculated per tablet, not per blister.

Storage

Below 25°C - Protect from sunlight, Protect from humidity